You are not logged in. Only partial content from this topic will be available to you. To view the full content, you must log in to your account. Don't have a login? Register now. Or, check out our Preview.
Syllabus Topic II: The Administration and Dosing of Cannabis Products
The Approved Cannabis Products and the Approved Modes of Administration in New York State
In this part of the course, we will discuss the approved cannabis products and the approved modes of administration in New York State. We will also discuss the pharmacologic profile of cannabis for each of the modes of administration. We will end this part of the course with a description of cannabis vaporizers.
The approved cannabis products and routes of administration in New York State are:
(1) Liquid or oil preparations for metered oromucosal or sublingual administration or administration per tube
(2) Metered liquid or oil preparations for vaporization
(3) Capsules for oral administration.
Note: Smoking as a method of administration of medical cannabis is expressly prohibited by New York State’s Compassionate Care Act, and edible products containing cannabis are not an approved form of medical cannabis in New York State.
New York State has specific regulations on how the products are to be dispensed.
Every dispensed cannabis product will be labeled with a specific concentration of total Tetrahydrocannabinol (THC) and total Cannabidiol (CBD).
Each cannabis product will have a maximum of 10mg total THC per dose.
Each registered organization will offer at least one cannabis product that has a low THC and a high CBD content (e.g., a 1:20 ratio of THC:CBD), and at least one cannabis product that has approximately equal amounts of THC and CBD.
Unprocessed whole flower form will not be made available to certified patients.